1、 Rule Summary 
 
     In order to efficiently allocate examination related resources to address the backlog of pending applications, and given the small number of requests for accelerated examination and the existence of a statutory procedure (Track One, priority examination) to expedite patent application processing, USPTO has decided to discontinue the accelerated examination program in invention patent applications and modify its practice rules to clarify the reasons for granting special processing petitions and fee requirements. 
 
     2、 Background information 
 
     The USPTO regulation (37 CFR 1.102) allows for early examination of patent applications based on "special processing petitions". In 2006, USPTO implemented an accelerated review program, allowing eligible applications to be reviewed in advance by submitting special processing petitions. However, the Track One priority review process implemented in 2011 provided a more convenient pathway for priority review, resulting in a significant decrease in participation in the accelerated review program. 
 
     3、 Details of Rule Revision 
 
     1. Stop the accelerated review plan 
 
     Due to the low usage rate of the accelerated examination program and the popularity of the Track One program, USPTO has decided to discontinue the accelerated examination program in invention patent applications. This plan will continue to apply to design patent applications, as there is currently no alternative expedited examination procedure for design patent applications. 
 
     2. Revision of practical rules 
 
     Reason for removing special treatment without cost: Remove the provision in 37 CFR 1.102 (c) (2) that allows special treatment to be obtained without cost for inventions that significantly improve environmental quality, promote energy resource development and utilization, or combat terrorism. 
 
     Clarify the reasons for special treatment that do not require fees: Amend 37 CFR 1.102 (c) to clarify that special treatment petitions may be based on the age or health condition of the inventor or co inventor and do not require payment of fees, to reflect changes in the Leahy Smith American Inventors Act (AIA).